2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
Lung
2024 ASCO® Annual Meeting Insights Hub
SCLC Treatment Evolution - Debunking Myths, IO Advances, and Long-Term Strategies
FEATURING
Anne Chiang
- 485 views
- July 10, 2024
- 3
ecancer
ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials
FEATURING
Bishal Gyawali
- 105 views
- July 2, 2024
- 1
ecancer
ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance vs. Local Consolidative Therapy in Limited mNSCLC"
FEATURING
Puneeth Iyengar
- 39 views
- July 2, 2024
ecancer
ASCO® 2024 Lung Cancer Updates: CROWN, ADRIATIC, and LAURA Trials
FEATURING
Luis Raez
- 69 views
- July 2, 2024
- 1
ecancer
ASCO® 2024 Insights: "HARMONi-A Study - Ivonescimab + Chemo for EGFRm NSCLC Patients Who Progressed on EGFR-TKI Treatment"
FEATURING
Li Zhang
- 33 views
- July 2, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOMA-3 Trials
FEATURING
Luis Raez
- 735 views
- June 14, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, ADRIATIC, KRYSTAL-12, and LAURA Trials
FEATURING
Balazs Halmos
- 937 views
- June 21, 2024
- 11
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring KRASG12C Mutations"
FEATURING
Tony Mok
- 458 views
- June 13, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "RAGNAR Trial - Erdafitinib Efficacy & Safety in Advanced NSCLC With FGFR Alterations"
FEATURING
Martin Schuler
- 135 views
- June 6, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "SAVE Study - Comparing Suspension vs. Continuation of PD-1 Pathway Blockade in Advanced NSCLC"
FEATURING
Yasushi Goto
- 232 views
- June 13, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "BEAT Trials and Neoadjuvant Strategies - Advances in ES-SCLC and Mesothelioma Treatment"
FEATURING
Melina Marmarelis
- 264 views
- June 20, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NSCLC), HERKULES-3 Trial (CRC), Novel Agents in ER+/HER2- BC
FEATURING
Vivek Subbiah
- 693 views
- June 14, 2024
- 5
ecancer
ASCO® 2024 Insights: "ADRIATIC Study - Durvalumab as Consolidation Treatment After Concurrent Platinum-Based CRT for LS-SCLC"
FEATURING
David Spigel
- 87 views
- June 21, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "TROPION-Lung05 Study - Intracranial Efficacy of Dato-DXd in Patients With Previously Treated Advanced/Metastatic NSCLC With Actionable Genomic Alterations"
FEATURING
Aaron Lisberg
- 200 views
- June 21, 2024
- 2
ecancer
ASCO® 2024 Insights: "LAURA Study - Osimertinib After Definitive CRT in Patients With Unresectable Stage 3 EGFRm NSCLC"
FEATURING
Suresh Ramalingam
- 64 views
- June 21, 2024
ecancer
ASCO® 2024 Insights: "Telehealth Palliative Care for Advanced Lung Cancer - Effective Alternative to In-Person Visits"
FEATURING
Joseph Greer
- 30 views
- June 20, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "HARMONi-A Trial - Ivonescimab Combined With Chemo in Patients With EGFRm non-Squamous NSCLC Who Progressed on EGFR-TKI Treatment"
FEATURING
Li Zhang
- 131 views
- June 17, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ETOP 13-18 BEAT-meso Trial - Bevacizumab + Chemo +/- Atezolizumab as 1L Treatment for Advanced Pleural Mesothelioma"
FEATURING
Sanjay Popat
- 100 views
- June 17, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "LIBRETTO-432 Trial - Adjuvant Selpercatinib vs. Placebo in Stage IB-IIIA RET+ NSCLC"
FEATURING
Jonathan Goldman
- 164 views
- June 14, 2024
- 1
ecancer
ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring a KRASG12C Mutation"
FEATURING
Robert Jotte
- 194 views
- June 21, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CHRYSALIS-2 Trial - Amivantamab + Lazertinib in Atypical EGFRm Advanced NSCLC"
FEATURING
Byoung Chul Cho
- 68 views
- June 14, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Assessing Secular Trends in Lung Cancer Stage in The United States Community Oncology Setting From 2013 to 2023"
FEATURING
Jessica Paulus
- 106 views
- June 12, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance Systemic Therapy +/- Local Consolidative Therapy in Limited mNSCLC"
FEATURING
Puneeth Iyengar
- 89 views
- June 13, 2024
2024 ASCO® Annual Meeting Insights Hub
Impact on Biomarker Documentation in Community Oncology by Optimizing Clinical Decision Support for adjNSCLC, mNSCLC, and mCRPC
FEATURING
Daniel Rubin
- 316 views
- June 13, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Evolution Trial - RT-Free Pembro + Chemo in High PD-L1 LA-NSCLC"
FEATURING
Akito Hata
- 129 views
- June 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "MIST5 Trial - Niraparib & Dostarlimab in Platinum-Sensitive Relapsed Mesothelioma"
FEATURING
Dean Fennell
- 111 views
- June 6, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Multi-Center Phase II Trial Investigating Safety & Efficacy of Osimertinib + Consolidative SABR in Advanced EGFRm NSCLC"
FEATURING
Sawsan Rashdan
- 52 views
- June 10, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "PALOMA-2 Study - Subcutaneous Amivantamab & Lazertinib as 1L Treatment in Patients With EGFRm Advanced NSCLC"
FEATURING
Sun Min Lim
- 130 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "First-in-Human Trial of RSO-021 in Malignant Pleural Effusion Caused by Mesothelioma and Advanced Tumors"
FEATURING
Dean Fennell
- 29 views
- June 6, 2024